Is the trial treatment using one's own antibodies suitable for treating AML leukemia?
Immunotherapy approaches that modify your immune system to target cancer cells are being explored for AML. These include CAR T-cell therapy, which uses modified versions of your own immune cells to fight leukemia.
However, immunotherapy Show Full Answer
Is the trial treatment using one's own antibodies suitable for treating AML leukemia?
Immunotherapy approaches that modify your immune system to target cancer cells are being explored for AML. These include CAR T-cell therapy, which uses modified versions of your own immune cells to fight leukemia.
However, immunotherapy is more established for other leukemia types like ALL and CLL. For AML specifically, the standard treatments remain chemotherapy, targeted therapies, and stem cell transplants.
Since you're on venetoclax combined with azacitidine, you're already receiving a well-established treatment combination for AML. This regimen is commonly used and has shown effectiveness.
Clinical trials are highly recommended for people with leukemia at any stage of treatment - not just as a last resort. They offer access to new therapies, including novel immunotherapy approaches that might be suitable for AML.
It's worth discussing with your oncologist whether any clinical trials involving immunotherapy or antibody-based treatments are available and appropriate for your specific AML subtype and treatment history.
February 28
Join
Your Privacy Choices
